Search research articles
Contact Us
Filters
Showing results (1-10 of 35) with videos related to
Page
of 4
Sort By:
Current Opinion in Molecular Therapeutics
|
March 1, 2005
Technology evaluation: colostrinin, ReGen
Marcus Rattray
Journal of Neurochemistry
|
January 10, 2012
New insights on regulation of LMTK2, a membrane kinase integrating pathways central to neurodegeneration
Marcus Rattray
Springerplus
|
July 8, 2016
Elucidating the mechanisms of TDP-43 aggregation in a cellular model of motor neuron disease
David Hicks, Marcus Rattray
Experimental Neurology
|
June 30, 2006
Does excitotoxic cell death of motor neurons in ALS arise from glutamate transporter and glutamate receptor abnormalities?
Marcus Rattray, Caterina Bendotti
BMC Neuroscience
|
April 7, 2012
Riluzole neuroprotection in a Parkinson's disease model involves suppression of reactive astrocytosis but not GLT-1 regulation
Marica Carbone, Susan Duty, Marcus Rattray
Neurochemistry International
|
November 15, 2011
Riluzole elevates GLT-1 activity and levels in striatal astrocytes
Marica Carbone, Susan Duty, Marcus Rattray
Molecular and Cellular Neurosciences
|
July 21, 2009
NG2 cells differentiate into astrocytes in cerebellar slices
Giampaolo Leoni, Marcus Rattray, Arthur M Butt
Journal of Psychopharmacology (Oxford, England)
|
March 3, 2006
Serotonin transporter expression is not sufficient to confer cytotoxicity to 3,4-methylenedioxymethamphetamine (MDMA) in vitro
Shaista Hayat, Robert J Williams, Marcus Rattray
Journal of Neurochemistry
|
May 13, 2014
Neuronal influences are necessary to produce mitochondrial co-localization with glutamate transporters in astrocytes
Christopher I Ugbode, Warren D Hirst, Marcus Rattray
Neurochemical Research
|
April 22, 2016
Astrocytes Grown in Alvetex(®) Three Dimensional Scaffolds Retain a Non-reactive Phenotype
Christopher I Ugbode, Warren D Hirst, Marcus Rattray
Page
of 4
Search research articles
Search
Showing results (1-10 of 35) with videos related to
Sort By:
Page
of 4
Current Opinion in Molecular Therapeutics
|
March 1, 2005
Technology evaluation: colostrinin, ReGen
Marcus Rattray
Journal of Neurochemistry
|
January 10, 2012
New insights on regulation of LMTK2, a membrane kinase integrating pathways central to neurodegeneration
Marcus Rattray
Springerplus
|
July 8, 2016
Elucidating the mechanisms of TDP-43 aggregation in a cellular model of motor neuron disease
David Hicks, Marcus Rattray
Experimental Neurology
|
June 30, 2006
Does excitotoxic cell death of motor neurons in ALS arise from glutamate transporter and glutamate receptor abnormalities?
Marcus Rattray, Caterina Bendotti
BMC Neuroscience
|
April 7, 2012
Riluzole neuroprotection in a Parkinson's disease model involves suppression of reactive astrocytosis but not GLT-1 regulation
Marica Carbone, Susan Duty, Marcus Rattray
Neurochemistry International
|
November 15, 2011
Riluzole elevates GLT-1 activity and levels in striatal astrocytes
Marica Carbone, Susan Duty, Marcus Rattray
Molecular and Cellular Neurosciences
|
July 21, 2009
NG2 cells differentiate into astrocytes in cerebellar slices
Giampaolo Leoni, Marcus Rattray, Arthur M Butt
Journal of Psychopharmacology (Oxford, England)
|
March 3, 2006
Serotonin transporter expression is not sufficient to confer cytotoxicity to 3,4-methylenedioxymethamphetamine (MDMA) in vitro
Shaista Hayat, Robert J Williams, Marcus Rattray
Journal of Neurochemistry
|
May 13, 2014
Neuronal influences are necessary to produce mitochondrial co-localization with glutamate transporters in astrocytes
Christopher I Ugbode, Warren D Hirst, Marcus Rattray
Neurochemical Research
|
April 22, 2016
Astrocytes Grown in Alvetex(®) Three Dimensional Scaffolds Retain a Non-reactive Phenotype
Christopher I Ugbode, Warren D Hirst, Marcus Rattray
Page
of 4